Human Serum Albumin Binding with Cotarnine Derivatives and Its Hemostatic, Wound-Healing, and Antibacterial Activities: Experimental and Molecular Docking Studies
Molecular Pharmaceutics · 2026
DOI: 10.1021/acs.molpharmaceut.6c00186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Laxmipriya Prusty und 8 weiteren Autor:innen. Beteiligte Einrichtung: Biophysical and Protein Chemistry Lab, Department of Chemistry, National Institute of Technology, Rourkela769008, India. Hauptthemen laut MEDLINE: Wound Healing, Anti-Bacterial Agents, Serum Albumin, Human, Hemostatics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Abstract (Originalsprache)
Human serum albumin (HSA) plays a key role in regulating the transport and bioavailability of therapeutic molecules, making protein–ligand interaction studies essential for assessing biomedical compatibility. In this work, the interaction of cotarnine and its derivatives with HSA was systematically investigated using spectroscopic, thermodynamic, and molecular docking approaches, along with evaluation of antibacterial, wound healing, and hemostatic activities. Spectroscopic analyses confirmed efficient binding of the derivatives to HSA without disrupting its native secondary structure, while thermodynamic studies revealed spontaneous, enthalpy-driven interactions dominated by noncovalent forces. Docking studies identified favorable binding orientations within HSA binding pockets, complementing the experimental results. All derivatives of cotarnine show greater binding and biological activity, such as wound healing and hemostatic, than cotarnine. Among the derivatives, L2 exhibited the strongest binding affinity and superior biological performance, which can be attributed to enhanced hydrophobic interactions arising from its chloro-substituted aromatic moiety. Overall, the combined biophysical, computational, and biological findings highlight cotarnine derivatives, particularly L2, as promising multifunctional candidates for wound-healing and related biomedical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biophysical and Protein Chemistry Lab, Department of Chemistry, National Institute of Technology, Rourkela769008, India.
- Department of Life Science, Neural Developmental Biology Lab, National Institute of Technology, Rourkela769008, India.
- Biotechnology and Medical Engineering, National Institute of Technology, Rourkela769008, India.
- Department of Chemistry, Berhampur University, Ganjam, Berhampur760007, India.
- Department of Chemical Sciences, IISER Berhampur, Ganjam, Brahmapur760003, India.
- Centre for Nanomaterials, National Institute of Technology, Rourkela769008, India.
ORCID-Profile: Devendra Verma, Harekrushna Sahoo
Zitieren
APA
Prusty, L., Panda, S., Naik, S., Roy, S., Behera, P. K., Rout, L., Verma, D., Mishra, M., & Sahoo, H. (2026). Human Serum Albumin Binding with Cotarnine Derivatives and Its Hemostatic, Wound-Healing, and Antibacterial Activities: Experimental and Molecular Docking Studies. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c00186
Vancouver
Prusty L, Panda S, Naik S, Roy S, Behera PK, Rout L, et al. Human Serum Albumin Binding with Cotarnine Derivatives and Its Hemostatic, Wound-Healing, and Antibacterial Activities: Experimental and Molecular Docking Studies. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.6c00186
BibTeX
@article{Prusty2026,
author = {Prusty, Laxmipriya and Panda, Smrutimayee and Naik, Seekha and Roy, Samadrita and Behera, Pradyota Kumar and Rout, Laxmidhar and Verma, Devendra and Mishra, Monalisa and Sahoo, Harekrushna},
title = {Human Serum Albumin Binding with Cotarnine Derivatives and Its Hemostatic, Wound-Healing, and Antibacterial Activities: Experimental and Molecular Docking Studies},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.6c00186}
}
EUVIMED